Effect of Incentive Spirometery on Asthmatic Pregnant Women

Cairo University60 enrolled

Overview

The purpose of this study is to determine the effect of the incentive spirometer on asthma during pregnancy.

This study will provide an evidence basis for obstetricians and physical therapist for women's health about the effect of spirometry on asthma during pregnancy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Asthmatic Pregnant With Complication

Interventions

pulmicort inhalerDRUG

Each woman in both groups (A\&B) will receive pulmicort inhaler on needs.

Incentive spirometer treatmentDEVICE

Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.

Eligibility

Sex: ALLMin age: 30 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: The patients will have the following criteria: 1. Their age will range from 30 to40years old. 2. Body mass index (BMI) will range from 25-29.9 kg/m2. 3. All patients will be clinically and medically stable. Exclusion Criteria: Patients will be excluded from the study if they have the following: 1. Diabetes mellitus. 2. Severe hypertension. 3. Neurological and neuromuscular disorders. 4. Blindness. 5. Developed moderate and severe degree of pleural effusion. 6. Cardiovascular instability. 7. Chronic chest disease.

Locations (1)

Outpatient clinic faculty of physical therapy cairo university

Dokki, Egypt

Outcomes

Primary Outcomes

Assessing the change in lung functions

The spirometer will be used for assessment of lung functions including total lung capacity (TLC) (litre), which is the most widely used functional index in the asthma follow up.

Time frame: at baseline and after 6 weeks of intervention

Assessing the change in symptoms of asthma

The Asthma Control Test provides a numerical score to help you and your healthcare provider determine if your asthma symptoms are well controlled. Take this test if you are 12 years or older. Share the score with your healthcare provider.

Time frame: at baseline and after 6 weeks of intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.